Search Results
Jun 03, 2026, 17:13 ET Thea Serves Its One Billionth Practice Question, Cementing Its Place as a Leader in AI-Powered Active Learning
Every single one of those questions is a student who showed up, put in the work, and trusted us to help them succeed."Transactional AI vs. Transformational AI: Thea Chose a SideMost AI tools offer students a shortcut: type in a question, get the answer back. It's fast, it's
More news about: Thea Study
Jun 03, 2026, 16:05 ET ADC Therapeutics Announces Results From LOTIS-5 Phase 3 Confirmatory Clinical Trial of ZYNLONTA® in Combination with Rituximab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
arms (98.5% vs. 97.5%). Higher rates of SAEs were seen in the test arm (49.0% vs. 34.5%). Grade ≥3 TEAEs observed in > 5% of patients were hematologic (40.7% vs. 59.4%), followed by infection/infestations (24.5% vs. 15.7%), then hepatotoxicity (17.2% vs. 8.1%) and oedema/effusion (7.4% vs. 0.5%) when
More news about: ADC Therapeutics SA
Jun 03, 2026, 16:00 ET FOX NEWS CHANNEL OUTPACES ABC NOTCHING HIGHEST RATED MAY DURING MIDTERM ELECTION YEAR IN NETWORK HISTORY
viewers and down 18% with A25-54 vs. April 2026)CNN: 460,000 total viewers and 72,000 A25-54 (down 23% with viewers and down 22% with A25-54 vs. April 2026)MS NOW: 595,000 total viewers and 61,000 A25-54 (down 21% with viewers and down 24% with A25-54 vs. April 2026)MONDAY –
More news about: Fox News Network, LLC
Jun 03, 2026, 15:33 ET EUROPÄISCHE KOMMISSION ERTEILT ZULASSUNG FÜR IMDYLLTRA® VON AMGEN FÜR DIE BEHANDLUNG VON KLEINZELLIGEM LUNGENKREBS IM FORTGESCHRITTENEN STADIUM
während oder nach einer Linie einer platinbasierten Chemotherapie fortgeschritten war, um mehr als fünf Monate signifikant verlängerte (mediane OS: 13,6 vs. 8,3 Monate; Hazard Ratio (HR), 0,60; 95% Konfidenzintervall (CI): 0,47, 0,77; P < 0,001).1 „Patienten mit kleinzelligem Lungenkrebs
More news about: Amgen
Jun 03, 2026, 15:16 ET LA COMMISSION EUROPÉENNE APPROUVE IMDYLLTRA® D'AMGEN POUR LE TRAITEMENT DU CANCER DU POUMON À PETITES CELLULES DE STADE ÉTENDU
chimiothérapie standard dans le traitement des patients atteints de CPPC-SE ayant progressé après une chimiothérapie à base de platine (SG médiane : 13,6 vs. 8,3 mois ; hazard ratio (HR), 0,60 ; intervalle de confiance à 95 % (IC) : 0,47, 0,77 ; P < 0,001).1 « Les patients atteints d'un
More news about: Amgen
Jun 03, 2026, 14:25 ET EURÓPSKA KOMISIA SCHVÁLILA LIEK IMDYLLTRA® SPOLOČNOSTI AMGEN NA LIEČBU POKROČILÉHO ŠTÁDIA MALOBUNKOVÉHO KARCINÓMU PĽÚC
(SOC) v liečbe pacientov s ES-SCLC, u ktorých došlo k progresii ochorenia počas jednej línie chemoterapie na báze platiny alebo po nej (medián OS: 13,6 vs. 8,3 mesiaca; pomer rizík (HR), 0,60; 95 % interval spoľahlivosti (IS): 0,47, 0,77; p < 0,001).1 „Pacienti s malobunkovým karcinómom
More news about: Amgen
Jun 03, 2026, 14:00 ET World Giving Report revela fatores que aumentam a generosidade para boas causas
Ásia.Como proporção da renda, a faixa etária mais generosa é de 25 a 44 anos que doam o dobro de sua renda em média do que aqueles com mais de 55 anos (1,2% vs 0,6%). As causas religiosas são mais populares para doações, apoiadas por 31% das pessoas. Isso é seguido por crianças e jovens e alívio da pobreza,
More news about: Charities Aid Foundation
Jun 03, 2026, 13:35 ET EVROPSKÁ KOMISE SCHVÁLILA PŘÍPRAVEK IMDYLLTRA® OD SPOLEČNOSTI AMGEN K LÉČBĚ EXTENZIVNÍHO STADIA MALOBUNĚČNÉHO KARCINOMU PLIC
(standard of care, SOC) u pacientů s ES-SCLC, u nichž došlo k progresi onemocnění během nebo po jedné linii chemoterapie na bázi platiny (medián OS: 13.6 vs. 8,3 měsíce; poměr rizik (HR), 0,60; 95% interval spolehlivosti (CI): 0,47, 0,77; P < 0,001).1 „Pacienti s malobuněčným
More news about: Amgen
Jun 03, 2026, 12:12 ET dltHub Named 2026 Snowflake Startup Program Product Partner of the Year
Analytics, a ~20-person data consultancy (Amsterdam & London). Per the dltHub × Tasman case study: 20 minutes from API docs to a running pipeline (vs. ~2 weeks previously); a mid-level engineer ships a production-quality REST API connector in an afternoon that previously required a senior engineer
More news about: dltHub
Jun 03, 2026, 12:06 ET dltHub Named 2026 Snowflake Startup Program Product Partner of the Year
Analytics, a ~20-person data consultancy (Amsterdam & London). Per the dltHub × Tasman case study: 20 minutes from API docs to a running pipeline (vs. ~2 weeks previously); a mid-level engineer ships a production-quality REST API connector in an afternoon that previously required a senior engineer
More news about: dltHub
Jun 03, 2026, 12:04 ET RedHill Biopharma Advancing Opaganib Options For Ebola Virus Disease Outbreak
of care (remdesivir + corticosteroids): 6.98% (n=3/43) opaganib + SoC vs. 23.4% (n=11/47) placebo + SoC (p=0.034))Improved median time to viral RNA clearance by ≥4 days in opaganib-treated patients (median 10 days vs. not reached by Day 14 in placebo, HR 1.34, p=0.043)Demonstrated
More news about: RedHill Biopharma Ltd.
Jun 03, 2026, 11:28 ET Geladeiras LG combinam tecnologias para conservar alimentos frescos por mais tempo
reorganizou suas operações em quatro divisões de negócios: Home Appliance Solution (HS), Media Entertainment Solution (MS), Vehicle Solution (VS) e Eco Solution (ES), redefinindo seus papéis e identidades para acelerar sua visão de futuro até 2030. Em 2024, as quatro divisões combinadas
More news about: LG Electronics Brasil
Jun 03, 2026, 10:08 ET In HelloNation, Esthetics Expert Valen Perez Explains Microneedling vs. Chemical Peels
Microneedling vs. Chemical Peels: What You Need to Know Before Choosing features insights from Valen Perez, Esthetics Expert of Fayetteville, NC, in HelloNation.About
More news about: HelloNation
Jun 03, 2026, 10:00 ET Hospitality Hiring Jumps 30% Across World Cup 2026 Host Cities - OysterLink
MetroMay 2026 vs. Jan–Apr 2026 Monthly AveragePhiladelphia
More news about: OysterLink
Jun 03, 2026, 09:47 ET El Parque Vehicular (VIO) de Vehículos Ligeros en Brasil Alcanza un Récord de 51.5 Millones, Reporta IDF
años, impulsando la demanda de repuestos. Aunque madura, es menor a los 16.2 años registrados por IDF en México.Desempeño del Mercado: 2025 vs. 2024
More news about: IDF - Integrate Data Facts LLC
Jun 03, 2026, 09:47 ET Brazil's Light Vehicles in Operation (VIO) Reach Record 51.5 Million, Reports Integrate Data Facts (IDF)
While maturing, Brazil's average vehicle age remains below the 16.2-year average IDF recently recorded for Mexico.2025 Market Performance vs. 2024Metric
More news about: IDF - Integrate Data Facts LLC
Jun 03, 2026, 09:47 ET Frota Circulante (VIO) de Veículos Leves no Brasil Atinge Recorde de 51,5 Milhões, Relata IDF
Embora em maturação, a idade média brasileira é menor que os 16,2 anos registrados recentemente pela IDF no México.Desempenho do Mercado: 2025 vs. 2024
More news about: IDF - Integrate Data Facts LLC
Jun 03, 2026, 09:00 ET LKQ Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in LKQ Corporation Securities Lawsuit - Contact Levi & Korsinsky
Promise vs. Reality: The LKQ Corporation Performance GapNEW YORK, June 3, 2026 /PRNewswire/ -- "Minimal integration risk." That was the promise. A $200 million revenue miss and accelerating market share losses
More news about: Levi & Korsinsky, LLP
Jun 03, 2026, 09:00 ET CALX DEADLINE: Levi & Korsinsky Reminds Calix, Inc. Investors of Upcoming Securities Class Action Deadline
reversal after eight consecutive quarters of improvement, suggesting internal cost pressures had already materializedInside Knowledge vs. Public StatementsThe action alleges that while the company publicly celebrated record margins and continued revenue growth, management
More news about: Levi & Korsinsky, LLP
Jun 03, 2026, 09:00 ET BW Investor Alert: Babcock & Wilcox Enterprises Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Defendants Allegedly Concealed Contract Risks: Levi & Korsinsky
fixed fee, with the remainder contingent on variable charges the Company declined to detail for five additional weeksInside Knowledge vs. Public StatementsWhile management promoted a "$10 billion global pipeline" and described the project's impact as "profound," the securities
More news about: Levi & Korsinsky, LLP
Jun 03, 2026, 09:00 ET POET DEADLINE: Levi & Korsinsky Reminds POET Technologies Inc. Investors of Upcoming Securities Class Action Deadline
discussion of purchase order details or shipping timelines could trigger contractual termination rightsRegulatory Reality: Boilerplate vs. Specific Known RisksThe SEC requires companies to disclose specific, known risks rather than relying on generic cautionary language. As pleaded
More news about: Levi & Korsinsky, LLP
Jun 03, 2026, 09:00 ET IMMP DEADLINE: Levi & Korsinsky Reminds Immutep Limited Investors of Upcoming Securities Class Action Deadline
internal data raised questions about whether the efti combination was performing adequately against the control armInside Knowledge vs. Public StatementsThe securities action alleges that Defendants possessed the power and authority to control Immutep's SEC filings,
More news about: Levi & Korsinsky, LLP
Jun 03, 2026, 09:00 ET AMGEN TO PRESENT NEW DATA ACROSS RARE AUTOIMMUNE AND INFLAMMATORY DISEASES AT EULAR 2026
4, Randomized, Double-blind Multicenter Non-inferiority Trial Evaluating the Efficacy and Safety of Intravenous Pegloticase Administered Every 4 Weeks vs Every 2 Weeks with Weekly MethotrexateAbstract #OP0294, Basic and Clinical Abstract Session: Beyond Hyperuricemia - New Insights into Gout
More news about: Amgen
Jun 03, 2026, 08:00 ET Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics
reduced mean time to detection by approximately three hours (~15%) compared with the previous-generation BD BACTEC™ FX Blood Culture System (17 hours vs. 20 hours). Faster detection enables earlier pathogen identification and more timely targeted antimicrobial therapy for patients with suspected bloodstream
More news about: Waters Corporation
Jun 03, 2026, 08:00 ET Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics
reduced mean time to detection by approximately three hours (~15%) compared with the previous-generation BD BACTEC™ FX Blood Culture System (17 hours vs. 20 hours). Faster detection enables earlier pathogen identification and more timely targeted antimicrobial therapy for patients with suspected bloodstream
More news about: Waters Corporation